23 March 2022 : Clinical Research
Intravenous Lidocaine for Postoperative Analgesia in 90 patients After Total Knee Arthroplasty and Limb Fractures
Rajmonda Nallbani
1ABCDEFG*, Edmond Komoni2ABCDEF, Fatos Sada1ABCDEF, Ismet Q. Jusufi3ABCDEF, Antigona Hasani 1ABCDEF
DOI: 10.12659/MSM.935852
Med Sci Monit 2022; 28:e935852
Table 1 Demographic and clinical data of the patients included in the study.
| Lidocainen=40 | Controln=41 | P-value | |
|---|---|---|---|
| Gender F, n (%) | 17 (42.5) | 18 (45) | P=0.82 |
| Age (years) | 54.4±8.3 | 56.6±9.9 | P=0.28 |
| Wheight (kg) | 78.8±7.2 | 78.7±6.3 | P=0.94 |
| Height (cm) | 166.9±6.1 | 169.9±7.5 | P=0.34 |
| BMI, mean±SD | 23.6±2.2 | 23.2±1.9 | P=0.35 |
| Hypertension, n (%) | 22 (55) | 14 (35) | P=0.07 |
| Diabetes, n (%) | 1 (2.5) | 1 (2.5) | P=1.0 |
| Smoking, n (%) | 3 (7.5) | 4 (10) | P=0.69 |
| Alcohol consumption, n (%) | 0 (0) | 2 (5) | P=0.15 |
| Anesthesia time (min), mean±SD | 163.7±38.5 | 162.7±39.4 | P=0.90 |
| Surgical time (min), mean±SD | 141.5±41.7 | 138.1±39.2 | P=0.70 |
| Mobilization, mean±SD | 10.2±0.6 | 10.4±0.8 | P=0.21 |
| Length of hospital stay, mean±SD | 7.2±0.4 | 7.2±0.4 | P=0.79 |
| ASA, n (%) | |||
| 1 | 6 (15) | 8 (20) | P=0.14 |
| 2 | 32 (80) | 25 (62.5) | |
| 3 | 2 (5) | 7 (17.5) | |
| Nausea, vomiting, n (%) | 20 (50) | 15 (37.5) | P=0.26 |
| Additional analgesia, n (%) | 24 (42.1) | 33 (57.9) | P=0.03 |
| Morphine miliecuivalent, mean±SD | 37.2±19.2 | 54±4.5 | P<0.001 |
| Type of surgery, n (%) | |||
| Total knee arthroplasthy | 22 (55) | 24 (58.5) | P=0.74 |
| Femoral fractures | 18 (45) | 17 (41.5) | |
| Data are expressed as mean±standard deviation or numbers (proportion%). ASA – American Association of Anesthesiologists; BMI – body mass index. | |||